Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

10.62
-0.1600-1.48%
Post-market: 10.620.00000.00%19:30 EDT
Volume:126.31K
Turnover:1.35M
Market Cap:372.41M
PE:-88.50
High:10.88
Open:10.78
Low:10.59
Close:10.78
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.89M
Volume Ratio:0.64
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:8.77
PE(LYR):-31.16

Loading ...

Fennec Pharmaceuticals Q2 EPS USD $0.05

THOMSON REUTERS
·
Aug 11

Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 11

Fennec Pharmaceuticals Inc. Expected to Post Earnings of 1 Cent a Share - Earnings Preview

Reuters
·
Aug 07

Fennec Pharmaceuticals Schedules Second-Quarter 2026 Results Call

Reuters
·
Aug 05

Fennec Pharmaceuticals Former Director Rosty Raykov Disposes of 10,000 Common Shares Worth $95,800

Reuters
·
Aug 05

Fennec Pharma Former Director Rosty Raykov Disposes of 9,599 Common Shares for $99,926.59

Reuters
·
Jul 03

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 22

Fennec Pharmaceuticals shareholders elect directors at annual meeting

Reuters
·
Jun 15

Fennec grants 10,000 inducement stock options priced at $9 to new hire

Reuters
·
Jun 15

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 15

Fennec Pharmaceuticals highlights new ASCO studies on PEDMARK use to prevent cisplatin-induced hearing loss

Reuters
·
Jun 11

Fennec Pharmaceuticals held annual shareholder meeting, elected directors

Reuters
·
Jun 11

Fennec Announces Results of Annual Meeting

GlobeNewswire
·
Jun 11

Fennec Pharmaceuticals director Rosty Raykov disposes of common shares worth $93,790.14

Reuters
·
Jun 03

Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Sutro Biopharma (STRO)

TIPRANKS
·
May 22

Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 22

Fennec price target raised to $16 from $13 at H.C. Wainwright

TIPRANKS
·
May 22

U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday

Reuters
·
May 22

Fennec says Phase 1 PEDMARK trial in metastatic germ cell tumors opens for accrual

Reuters
·
May 22

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

GlobeNewswire
·
May 22